Abstract
This report presents confirming evidence for the immunizing value of a trivalent combined measles-mumps-rubella vaccine (M-M-R), based on studies with 188 children in Chile. All of the children de veloped antibody against measles virus and 96 per cent developed antibodies against mumps and rubella. No clinical reaction occurred other than that expected to follow measles vaccine given alone.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
